Home › Funds › Lion Point Capital, LP › HUMA
Lion Point Capital, LP position in HUMA
HUMACYTE INC · Health Care
Lion Point Capital, LP reported holding 650,000 shares of HUMA (HUMACYTE INC) in its Q2 2026 13F filing — a position valued at US$507K, representing 2.43% of its reported portfolio and ranking #17 among its reported holdings. Lion Point Capital, LP has disclosed HUMA holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Lion Point Capital, LP's HUMA position evolved
Lion Point Capital, LP first disclosed a stake in HUMA in Q3 2023 at 235,000 shares (US$689K). The position peaked in Q1 2024 at 235,000 shares, worth US$731K. Across 9 filings, Lion Point Capital, LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 650,000 shares valued at US$507K. Notable position changes include a 499% increase in Q4 2025 (shares fell 37% over the following quarter), a 30% increase in Q1 2026 (shares rose 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 235.00K | $688.55K | New |
| Q4 2023 | 235.00K | $667.40K | Hold |
| Q1 2024 | 235.00K | $730.85K | Hold |
| Q1 2025 | 83.50K | $142.37K | New |
| Q2 2025 | 83.50K | $174.51K | Hold |
| Q3 2025 | 83.50K | $145.29K | Hold |
| Q4 2025 | 500.00K | $480.25K | Add |
| Q1 2026 | 650.00K | $394.36K | Add |
| Q2 2026 | 650.00K | $507.26K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HUMA and 13F data
HUMA (HUMACYTE INC) is a Health Care company. 26 other funds we track also report a position in HUMA — the largest reported positions include GREAT POINT PARTNERS LLC (US$2.9M), LuminArx Capital Management LP (US$507K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HUMA
- GREAT POINT PARTNERS LLC 3.75M sh · $2.93M · Q2 2026
- LuminArx Capital Management LP 650.00K sh · $507.26K · Q2 2026
More on Lion Point Capital, LP
FAQ
How long has Lion Point Capital, LP held HUMA?
Lion Point Capital, LP has disclosed HUMA holdings in 9 of the last 12 reported quarters, going back to Q3 2023.
What is Lion Point Capital, LP's current position in HUMA?
As of Q2 2026, Lion Point Capital, LP holds 650.00K shares of HUMA (HUMACYTE INC), valued at $507.26K, representing 2.43% of its reported portfolio and ranking #17.
Has Lion Point Capital, LP been buying or selling HUMA?
In the latest 13F filing (Q2 2026), Lion Point Capital, LP held unchanged its position in HUMA. The position peaked in Q1 2024 at 235.00K shares.
Which other funds hold HUMA?
Other major institutional holders of HUMA include GREAT POINT PARTNERS LLC, LuminArx Capital Management LP, among 26 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.